Scorpion Venom Heat-Resistant Peptide is Neuroprotective against Cerebral Ischemia-Reperfusion Injury in Association with the NMDA-MAPK Pathway
- 39 Downloads
Scorpion venom heat-resistant peptide (SVHRP) is a component purified from Buthus martensii Karsch scorpion venom. Our previous studies have shown that SVHRP is neuroprotective in models of Alzheimer’s disease and Parkinson’s disease. The present study aimed to explore the potential neuroprotective effects of SVHRP on cerebral ischemia/reperfusion (I/R) injury, using a mouse model of middle cerebral artery occlusion/reperfusion (MCAO/R) and a cellular model of oxygen-glucose deprivation/reoxygenation (OGD/R). Our results showed that SVHRP treatment decreased the neurological deficit scores, edema formation, infarct volume and neuronal loss in the MCAO/R mice, and protected primary neurons against OGD/R insult. SVHRP pretreatment suppressed the alterations in protein levels of N-methyl-D-aspartate receptors (NMDARs) and phosphorylated p38 MAPK as well as some proinflammatory factors in both the animal and cellular models. These results suggest that SVHRP has neuroprotective effects against cerebral I/R injury, which might be associated with inhibition of the NMDA-MAPK-mediated excitotoxicity.
KeywordsScorpion venom heat-resistant peptide Cerebral ischemia/reperfusion injury Neuroprotection NMDARs p38 MAPK
This work was supported by grants from National Natural Science Foundation of China (81571061 and 81671061), the Scientific Study Project for Institutes of Higher Learning, Ministry of Education, Liaoning Province, China (LZ2017001), Liaoning Provincial Key R&D Program (2019JH2/10300043) and the Liaoning Revitalization Talents Program (XLYC1808031).
Conflict of interest
All authors claim that there are no conflicts of interest.
- 2.Jauch EC, Saver JL, Adams HP, Jr, Bruno A, Connors JJ, Demaerschalk BM, et al. American Heart Association Stroke Council; Council on Cardiovascular Nursing; Council on Peripheral Vascular Disease; Council on Clinical Cardiology: Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2013, 44: 870–947.CrossRefGoogle Scholar
- 10.Yin SM, Zhao D, Yu DQ, Li SL, An D, Peng Y, et al. Neuroprotection by scorpion venom heat resistant peptide in 6-hydroxydopamine rat model of early-stage Parkinson’s disease. Sheng Li Xue Bao 2014, 66: 658–666.Google Scholar
- 11.Zhang XG, Wang X, Zhou TT, Wu XF, Peng Y, Zhang WQ, et al. Scorpion venom heat-resistant peptide protects transgenic Caenorhabditis elegans from β-amyloid toxicity. Front Pharmacol 2016, 7: 227.Google Scholar
- 28.Krupinski J, Slevin M, Marti E, Catena E, Rubio F, Gaffney J. Time-course phosphorylation of the mitogen activated protein (MAP) kinase group of signalling proteins and related molecules following middle cerebral artery occlusion (MCAO) in rats. Neuropathol Appl Neurobiol 2003, 29: 144–158.CrossRefGoogle Scholar
- 38.Yan H, Li L, Tang XC. Treating senile dementia with traditional Chinese medicine. Clin Interv Aging 2007, 2: 201–208.Google Scholar
- 56.Jiang M, Li J, Peng Q, Liu Y, Liu W, Peng J, et al. Neuroprotective effects of bilobalide on cerebral ischemia and reperfusion injury are associated with inhibition of pro-inflammatory mediator production and down-regulation of JNK1/2 and p38 MAPK activation. J Neuroinflammation 2014, 11: 167.CrossRefGoogle Scholar
- 57.Strassburger M, Braun H, Reymann KG. Anti-inflammatory treatment with the p38 mitogen-activated protein kinase inhibitor SB239063 is neuroprotective, decreases the number of activated microglia and facilitates neurogenesis in oxygen-glucose-deprived hippocampal slice cultures. Eur J Pharmacol 2008, 592: 55–61.CrossRefGoogle Scholar